DUFFY; JOSEPH L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DUFFY; JOSEPH L..The latest application filed is for "allosteric modulators of nicotinic acetylcholine receptors".

Company Profile

1.15.31

DUFFY; JOSEPH L. - CRANFORD NJ
Duffy; Joseph L. - Plano TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20190337910 - CROWLEY; BRENDAN M. ; et al.	2019-11-07
Factor XIa inhibitors Grant 10,143,681 - Shen , et al. De	2018-12-04
Factor XIa inhibitors Grant 10,093,683 - Lim , et al. October 9, 2	2018-10-09
Allosteric modulators of nicotinic acetylcholine receptors Grant 9,926,285 - Crowley , et al. March 27, 2	2018-03-27
FACTOR XIa INHIBITORS App 20180050022 - Shen; Dong-Ming ; et al.	2018-02-22
Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20180030007 - Crowley; Brendan M. ; et al.	2018-02-01
Allosteric modulators of nicotinic acetylcholine receptors Grant 9,840,481 - Crowley , et al. December 12, 2	2017-12-12
Allosteric Modulators Of Nicotinic Acetylcholine Receptors App 20170275260 - CROWLEY; BRENDAN M. ; et al.	2017-09-28
FACTOR XIa INHIBITORS App 20170044183 - Lim; Yeon-Hee ; et al.	2017-02-16
Glucose-responsive Insulin Conjugates App 20160303244 - Lin; Songnian ; et al.	2016-10-20
Glucose-responsive Insulin Conjugates App 20160251407 - Lin; Songnian ; et al.	2016-09-01
Glucose-responsive Insulin Conjugates App 20150105317 - Lin; Songnian ; et al.	2015-04-16
Spiroxazolidinone compounds Grant 8,742,110 - Duffy , et al. June 3, 2	2014-06-03
Spiroxazolidinone Compounds App 20130131042 - Duffy; Joseph L. ; et al.	2013-05-23
Substituted Aryl Sulfone Derivatives As Calcium Channel Blockers App 20130040932 - Chakravarty; Prasun K. ; et al.	2013-02-14
Spiro Isoxazoline Compounds As Sstr5 Antagonists App 20130040978 - Duffy; Joseph L. ; et al.	2013-02-14
Substituted aryl sulfone derivatives as calcium channel blockers Grant 8,304,434 - Chakravarty , et al. November 6, 2	2012-11-06
N-substituted oxindoline derivatives as calcium channel blockers Grant 8,273,749 - Duffy , et al. September 25, 2	2012-09-25
Substituted Spirocyclic Amines Useful As Antidiabetic Compounds App 20120041012 - Aster; Susan D. ; et al.	2012-02-16
Substituted Aryl Sulfone Derivatives As Calcium Channel Blockers App 20110172236 - Chakravarty; Prasun K. ; et al.	2011-07-14
Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers App 20110136842 - Duffy; Joseph L. ; et al.	2011-06-09
N-substituted Oxindoline Derivatives As Calcium Channel Blockers App 20100216815 - Duffy; Joseph L. ; et al.	2010-08-26
Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers App 20100210620 - Chakravarty; Prasun K. ; et al.	2010-08-19
N-substituted Oxindoline Derivatives As Calcium Channel Blockers App 20100204247 - Duffy; Joseph L. ; et al.	2010-08-12
System and method providing for interoperability of session initiation protocol (SIP) and H.323 for secure realtime transport protocol (SRTP) session establishment Grant 7,764,669 - Mills , et al. July 27, 2	2010-07-27
Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators Grant 7,759,352 - Duffy , et al. July 20, 2	2010-07-20
2-substituted Indole Derivatives As Calcium Channel Blockers App 20100087446 - Chakravarty; Prasun K. ; et al.	2010-04-08
Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,671,073 - Duffy , et al. March 2, 2	2010-03-02
Substituted Imidazole-4-Carboxamides as Cholecystokinin -1 Receptor Modulators App 20090281117 - Duffy; Joseph L. ; et al.	2009-11-12
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,388,019 - Ashton , et al. June 17, 2	2008-06-17
Substituted piperizines for the treatment of pain App 20080139578 - Abbadie; Catherine ; et al.	2008-06-12
Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20080027093 - Duffy; Joseph L. ; et al.	2008-01-31
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,309,714 - Duffy , et al. December 18, 2	2007-12-18
.beta.-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,307,164 - Brockunier , et al. December 11, 2	2007-12-11
System and method providing for interoperability of session initiation protocol (SIP) and H.323 for secure realtime transport protocol (SRTP) session establishment App 20070201512 - Mills; David W. ; et al.	2007-08-30
Cyanothiophene derivatives, compositions containing such compounds and methods of use Grant 7,196,106 - Duffy , et al. March 27, 2	2007-03-27
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060111336 - Duffy; Joseph L. ; et al.	2006-05-25
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060074087 - Ashton; WallaceT ; et al.	2006-04-06
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20050107390 - Brockunier, Linda L. ; et al.	2005-05-19
Cyanothiophene derivatives, compositions containing such compounds and methods of use App 20040097552 - Duffy, Joseph L. ; et al.	2004-05-20
Cyanothiophene derivatives, compositions containing such compounds and methods of use App 20040097557 - Duffy, Joseph L. ; et al.	2004-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.